Citigroup’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-70
| Closed | – | – | 5598 |
|
|
2022
Q1 | $0 | Buy |
+70
| New | – | ﹤0.01% | 5557 |
|
|
2021
Q3 | – | Sell |
-7
| Closed | – | – | 5311 |
|
|
2021
Q2 | $0 | Sell |
7
-235
| -97% | – | ﹤0.01% | 5561 |
|
|
2021
Q1 | $5K | Sell |
242
-310
| -56% | -$6.41K | ﹤0.01% | 5227 |
|
|
2020
Q4 | $8K | Buy |
552
+410
| +289% | +$5.94K | ﹤0.01% | 4928 |
|
|
2020
Q3 | $2K | Sell |
142
-237
| -63% | -$3.34K | ﹤0.01% | 4922 |
|
|
2020
Q2 | $8K | Sell |
379
-389
| -51% | -$8.21K | ﹤0.01% | 4711 |
|
|
2020
Q1 | $15K | Buy |
768
+225
| +41% | +$4.4K | ﹤0.01% | 4488 |
|
|
2019
Q4 | $16K | Buy |
543
+409
| +305% | +$12.1K | ﹤0.01% | 4562 |
|
|
2019
Q3 | $6K | Sell |
134
-625
| -82% | -$28K | ﹤0.01% | 4736 |
|
|
2019
Q2 | $60K | Sell |
759
-3,895
| -84% | -$308K | ﹤0.01% | 3954 |
|
|
2019
Q1 | $307K | Buy |
+4,654
| New | +$307K | ﹤0.01% | 2838 |
|